Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Naurex
1801 Maple Avenue, Suite 4300
Evanston, IL 60201
Phone: 847-871-0377
www.naurex.com

Naurex Inc. is a clinical-stage private company developing novel therapies to address unmet needs in psychiatry and neurology based on a new mechanism of action for modulating the NMDA receptor in a safe way. Naurex's lead product GLYX-13 has shown promising antidepressant activity with excellent safety in a Phase II trial, confirming the efficacy signals and safety observed in Phase I and preclinical studies.

Key Contact
Name
Norbert Riedel
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
12/17/12 $38,000,000 Series B Adams Street Partners
Baxter Ventures
Druid Bioventures
Genesys Capital
Latterell Venture Partners
Lundbeck
Northwestern University
PathoCapital
Savitr Capital
Shire Strategic Investment Group
Takeda Ventures
12/03/14 $80,000,000 Series C Adams Street Partners
Baxter Ventures
Cowen Investments
Druid Bioventures
EcoR1 Capital
Genesys Capital
Goudy Park Capital
H. Lundbeck A/S
Latterell Venture Partners
PathoCapital
Portola Capital Partners
Sabby Capital


Featured Reading